General - Therapies
Total Payments
$24.0M
Transactions
19,570
Doctors
7,829
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $329,356 | 65 | 0 |
| 2022 | $23.3M | 18,690 | 7,744 |
| 2021 | $129,317 | 117 | 47 |
| 2020 | $246,587 | 670 | 186 |
| 2019 | $994.64 | 9 | 8 |
| 2018 | $412.92 | 9 | 9 |
| 2017 | $511.69 | 10 | 8 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $17.8M | 22 | 74.4% |
| Consulting Fee | $1.8M | 696 | 7.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.8M | 855 | 7.5% |
| Travel and Lodging | $1.2M | 4,319 | 5.1% |
| Food and Beverage | $828,576 | 13,516 | 3.5% |
| Unspecified | $329,356 | 65 | 1.4% |
| Grant | $101,954 | 3 | 0.4% |
| Education | $15,636 | 94 | 0.1% |
Payments by Type
General
$23.6M
19,505 transactions
Research
$329,356
65 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| INTERRUPT AF | Boston Scientific Corporation | $158,336 | 0 |
| Randomized Controlled Trial of Per-Oral Pancreatoscopy vs. Extracorporeal Shock-Wave Lithotripsy in Removing Symptomatic Obstructing Pancreatic Duct Stones | Boston Scientific Corporation | $60,000 | 0 |
| EUS-guided gastroenterostomy versus enteral stenting for palliation of malignant gastric outlet obstruction: a randomized clinical trial | Boston Scientific Corporation | $50,000 | 0 |
| RHYTHMIA vs CARTO in redo ablation Procedures for Atrial Fibrillation: The MAP-AF study | Boston Scientific Corporation | $46,000 | 0 |
| Assessing pacing Strategies in Cardiac Amyloidosis | Boston Scientific Corporation | $8,520 | 0 |
| Evaluation of the Impact of a Forward Viewing Scope at the Time of ERCP | Boston Scientific Corporation | $6,500 | 0 |
Top Doctors Receiving Payments for General - Therapies
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D., PH.D | Vascular & Interventional Radiology | Phoenix, AZ | $14.9M | 1 |
| Keith Terasaki | — | Los Angeles, CA | $1.6M | 1 |
| , M.D | Radiation Oncology | Grand Forks, ND | $680,844 | 1 |
| Unknown | — | Baltimore, MD | $387,009 | 120 |
| Leo Hopkins | — | Buffalo, NY | $241,497 | 1 |
| , M.D | Cardiovascular Disease | San Pablo, CA | $188,333 | 18 |
| , MD | Vascular & Interventional Radiology | Chicago, IL | $111,422 | 5 |
| Hugh Mcelderry | Clinical Cardiac Electrophysiology | Birmingham, AL | $101,374 | 4 |
| , MD | Cardiovascular Disease | Petoskey, MI | $91,646 | 37 |
| , M.D | Reproductive Endocrinology | Houston, TX | $77,942 | 1 |
| , MD | Specialist | Washington, DC | $75,859 | 13 |
| , M.D | Specialist | Jupiter, FL | $55,622 | 36 |
| , MD | Internal Medicine | Boston, MA | $51,954 | 2 |
| , MD | Ophthalmology | Stoneham, MA | $48,794 | 1 |
| , MD | Radiation Oncology | Miami, FL | $47,705 | 20 |
| , MD | Gastroenterology | Palo Alto, CA | $43,497 | 31 |
| , DO | Physical Medicine & Rehabilitation | Greenwood Village, CO | $42,517 | 53 |
| , MD | Diagnostic Radiology | Columbus, OH | $33,627 | 42 |
| , MD | Anesthesiology | Kirkland, WA | $29,526 | 31 |
| , MD | Plastic Surgery | San Diego, CA | $28,898 | 29 |
| , MD | Pain Medicine | Winston Salem, NC | $28,831 | 22 |
| , M.D | Vascular & Interventional Radiology | Seattle, WA | $26,470 | 18 |
| , MD | Urology | Scottsdale, AZ | $26,194 | 1 |
| , MD | Anesthesiology | Kent, OH | $26,190 | 26 |
| , M.D | Interventional Cardiology | Atlanta, GA | $26,186 | 5 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $24.0M
- Total Doctors 7,829
- Transactions 19,570
About General - Therapies
General - Therapies is a device associated with $24.0M in payments to 7,829 healthcare providers, recorded across 19,570 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2017 to 2024. In 2024, $329,356 was paid across 65 transactions to 0 doctors.
The most common payment nature for General - Therapies is "Acquisitions" ($17.8M, 74.4% of total).
General - Therapies is associated with 6 research studies, including "INTERRUPT AF" ($158,336).